Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001 Meeting Abstract


Authors: Robert, C.; Joshua, A. M.; Kefford, R.; Joseph, R. W.; Wolchok, J. D.; Hodi, F. S.; Hamid, O.; Weber, J. S.; Gangadhar, T. C.; Dronca, R. S.; Patnaik, A.; Zarour, H. M.; Hwu, W. J.; Hersey, P.; Daud, A.; Giannotti, M.; Li, X. N.; Ebbinghaus, S.; Kang, S. P.; Ribas, A.
Abstract Title: Association of immune-related thyroid disorders with pembrolizumab (pembro, MK-3475) in patients (pts) with advanced melanoma treated in KEYNOTE-001
Meeting Title: 51st Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901960
PROVIDER: wos
DOI: 10.1200/JCO.2015.33.15_suppl.9050
Notes: Meeting Abstract: 9050 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok